Cann Group Limited (ASX: CAN)
Australia
· Delayed Price · Currency is AUD 0.0480
+0.0010 (2.13%)
Nov 7, 2024, 4:10 PM AEST
Cann Group Company Description
Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivating, manufacturing, and selling medicinal cannabis in Australia and Europe.
It also licenses to undertake research and to cultivate cannabis for human medicinal and research purposes.
The company was founded in 2014 and is based in Port Melbourne, Australia.
Cann Group Limited
| Country | Australia |
| Founded | 2014 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Jennifer Pilcher |
Contact Details
Address: 262-276 Lorimer Street Port Melbourne, 3207 Australia | |
| Phone | 61 3 9095 7088 |
| Website | canngrouplimited.com |
Stock Details
| Ticker Symbol | CAN |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000CAN2 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jennifer Lee Pilcher AGIA, BBS, C.A. | Chief Executive Officer, MD and Executive Director |
| David Hine | Head of Finance |
| Steven Notaro BA, J.D. | Head of Legal and Regulatory Affairs and Company Secretary |